Multiple myeloma, nephrotic syndrome and crystalloid inclusions in podocytes
- 1 February 2006
- journal article
- case report
- Published by Elsevier BV in Kidney International
- Vol. 69 (3), 616-620
- https://doi.org/10.1038/sj.ki.5000144
Abstract
No abstract availableThis publication has 17 references indexed in Scilit:
- Collapsing glomerulopathy induced by long-term treatment with standard-dose pamidronate in a myeloma patientNephrology Dialysis Transplantation, 2004
- Podocyte injury associated glomerulopathies induced by pamidronateKidney International, 2004
- Toxic acute tubular necrosis following treatment with zoledronate (Zometa)Kidney International, 2003
- Pamidronate-induced tubulointerstitial nephritis with Fanconi syndrome in a patient with primary hyperparathyroidismNephrology Dialysis Transplantation, 2003
- Nephrotic proteinuria associated with high-dose pamidronate in multiple myelomaBritish Journal of Haematology, 2002
- Pamidronate-associated nephrotoxicity in a patient with Langerhans's histiocytosisAmerican Journal of Kidney Diseases, 2002
- Nephrotic syndrome after treatment with pamidronateAmerican Journal of Kidney Diseases, 2002
- Pamidronate-Related Nephrotoxicity (Tubulointerstitial Nephritis) in a Patient with Osteolytic Bone MetastasesNephron, 2001
- Renal Failure in Multiple MyelomaArchives of Internal Medicine, 1998
- Protease resistance and binding of Ig light chains in myeloma-associated tubulopathiesKidney International, 1995